Recompete Radar · NAICS
NAICS 541711 — Research and Development in Biotechnology
Federal contracts classified under NAICS 541711 whose current period of performance ends in the next 24 months.
5 contracts · $12,075M total
5 contracts
- CERUS CORPORATIONSBCERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT).$185.2MMar 31, 2027FY27 Q2 · 5 moOffice of Assistant Secretary for Preparedness and Response · NAICS 541711Record
- THE EMMES COMPANY, LLCSBDATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT$66.0MMay 28, 2027FY27 Q3 · 7 moNational Institutes of Health · NAICS 541711Record
- REGENERON PHARMACEUTICALS INC- REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD$278.8MSep 25, 2027FY27 Q4 · 11 moOffice of Assistant Secretary for Preparedness and Response · NAICS 541711Record
- MERCK SHARP & DOHME LLC$236.3MSep 27, 2027FY27 Q4 · 11 moOffice of Assistant Secretary for Preparedness and Response · NAICS 541711Record
- ALLIANCE FOR ENERGY INNOVATION, LLCAWARD OF CONTRACT TO MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORY$11.3BSep 30, 2028FY28 Q4 · 23 moDepartment of Energy · NAICS 541711Record
“Current end” is the end of the current period of performance in USAspending. Unexercised options can extend a contract, and agencies may recompete early or late — treat these dates as the start of your research, not a schedule.
Track these every week
The Small Business Wire lands every Monday with new awards and upcoming recompetes in your NAICS codes. Free.